Imported methicillin-resistant Staphylococcus aureus, SwedenArchived
The authors analyzed data on 444 imported cases of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden during the period 2000-2003. The risk for MRSA carriage or infection in returning travellers ranged from 0.1 per million travellers returning from Nordic countries to 59.4 per million travellers returning from North Africa and the Middle East.
Panton-Valentine leukocidin-positive Staphylococcus aureus infections in returning travelersArchived
The authors present data on 15 individuals infected by Panton-Valentine leukocidin (PVL) -producing strains of Staphylococcus aureus. Intra-familial spread was documented in one case, and occupational transmission was most likely in another case. spa typing of the strains revealed a broad range of variants, though some strains were clonally related. Methicillin-resistant Staphylococcus aureus (MRSA) was found in three cases.
Country-to-country transfer of patients and the risk of multi-resistant bacterial infectionArchived
This review outlines how increasing modalities of travel, such as aeromedical evacuation of civilians and of military personnel, medical tourism and any shared healthcare across countries, are risks for the transmission of multidrug-resistant organisms via the patient, from country to country.
Clostridium difficile infection in Europe: a hospital-based surveyArchived
Clostridium difficile infection is the leading cause of healthcare-associated diarrhoea in the developed world and represents a major financial burden for European healthcare systems.
Infection control measures to limit the spread of Clostridium difficileArchived
Clostridium difficile infection (CDI) is an intestinal infection usually acquired in hospital settings, after antibiotic treatment. The clinical spectrum of CDI ranges from mild diarrhoea to severe life-threatening pseudomembranous colitis. In the recent years, an increased incidence of CDI has been reported in Europe and worldwide.
US CDC guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) – 2012 CRE toolkitArchived
Carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are highly resistant to antibiotics, leaving only a few options for treatment of infected patients, and thus represent a serious threat to public health.
US CDC report on antibiotic resistance threats in the United States, 2013
Antimicrobial resistance represent a serious threat to public health and patient safety and is a worldwide problem. Each year, in the European Union (EU) at least 25 000 patients die of infections with multidrug-resistant bacteria.
Collection of online resources for prevention and control of antimicrobial resistance and healthcare-associated infections now available
ECDC gathered guidance documents on prevention and control of infection with carbapenem-resistant Enterobacteriaceae (CRE) available online, published by EU/EEA Member States, ECDC, other agencies and scientific societies.
New ECDC protocols for surveillance of healthcare-associated infections: targeted surveillance is an essential tool for control and prevention
Today, ECDC’s Healthcare-associated Infections Surveillance Network (HAI-Net) publishes a new version of the software application HelicsWin.Net.
ECDC updates its directory of online resources on infection prevention and control, in support of the WHO “SAVE LIVES: Clean Your Hands” campaign
To support the annual World Health Organization (WHO) “SAVE LIVES: Clean your Hands” campaign, ECDC is launching two new pages of its directory of online resources on infection prevention and control.